Table 1.

Patient Characteristics

Factor	No. (n = 162)	Percentage or IQR
Age at PCP diagnosis, years, median (IQR)	41	(35–46)
Male sex, n (%)	148	91.4
Race, n (%)
Asian/Pacific Islander	16	9.9
Black	36	22.2
Other	24	15.7
White	74	45.7
Unknown	10	6.2
Hispanic ethnicity	38	23.4
CD4 cell count at diagnosis, cells/μL, median (IQR)	49	15–105
HIV risk factor
Men who have sex with men	91	56.2
Heterosexual	37	22.8
Injection drug user	21	13.0
Other	13	8.6
HIV RNA level at PCP, log10 copies/mm3, median (IQR)	4.84	3.58–5.33
Interval
Before clinical trial ACTG 5164	118	72.8
After clinical trial ACTG 5164, before SFGH 5164 Initiative	26	16.1
After SFGH 5164 Initiative	18	11.1

Abbreviations: HIV, human immunodeficiency virus; IQR, interquartile range; PCP, Pneumocystis jirovecii pneumonia; SFGH, San Francisco General Hospital.